Dr. Melinda Elliott

Dr. Melinda Elliott is the Chief Medical Officer (CMO) of Prolacta Bioscience. Since joining Prolacta in 2016, she has served as the voice of the patient, working to ensure that the needs of premature infants are being articulated and that relevant treatment and product opportunities are identified. She is also a board-certified neonatologist with over 30 years of experience and has held professional and clinical positions with the Pediatrix Medical Group, The Johns Hopkins Hospital, Union Memorial Hospital, Franklin Square Hospital Center, and The Herman & Walter Samuelson Children’s Hospital at Sinai in Baltimore. Dr. Elliott has committed her career to the care of vulnerable, premature infants and has researched the benefits of an Exclusive Human Milk Diet (EHMD) for extremely l...